Badawi David 4
4 · Sight Sciences, Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) CTO David Badawi Sells 8,168 Shares
What Happened
- David Badawi, Chief Technology Officer and Director of Sight Sciences (SGHT), sold 8,168 shares of common stock on April 2, 2026. The shares were sold at a weighted average price of $3.48 for total proceeds of approximately $28,425. The sale is reported as an open-market/private sale and is coded as a sale (S).
Key Details
- Transaction date: 2026-04-02; filing date: 2026-04-03 (timely).
- Price: weighted average $3.48; trade price range $3.43–$3.59 across multiple transactions.
- Proceeds: ~$28,425.
- Shares held after the transaction: 1,804,359 shares outright plus 185,931 shares that will be acquired upon vesting of RSUs — total beneficial interest of 1,990,290 shares (per filing footnote).
- Footnotes: (F1) sale was to cover the reporting person’s tax liability related to RSU vesting; (F2) weighted-average price and range disclosure (reporter can provide per-price breakdown on request); (F3) ownership breakdown described above.
- Timeliness: Filing appears timely (reported the next day).
Context
- The sale was executed to satisfy tax withholding obligations tied to RSU vesting, which is a common, routine transaction for executives and does not by itself indicate a change in insider sentiment.
Insider Transaction Report
Form 4
Badawi David
DirectorChief Technology Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-04-02$3.48/sh−8,168$28,425→ 1,990,290 total
Footnotes (3)
- [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
- [F2]Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes (i) 1,804,359 shares of common stock, and (ii) 185,931 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi|2026-04-03